Reversible cardiogenic shock following 5-fluorouracil infusion.
Journal: Investigational New Drugs
Published:
Abstract
5-Fluorouracil remains a major component of chemotherapy regimens for various tumors. We report the case of reversible cardiogenic shock following 5-FU administration and discuss the different pitfalls of such toxicity. Oncologist should be aware of that rare but potentially lethal adverse event.
Authors
Charles Ferté, Carlos Gomez Roca, Yohann Loriot, Rastislav Bahleda, Cristian Moldovan, Ariel Cohen, Hassan Izzedine, Jean-charles Soria, Stephane Ederhy
Relevant Conditions